Human Amyloid Imaging 2020

Miami, Florida

15 – 17 January 2020

As methodology improves, the new tracer UCB-J reliably flags synapse loss in Alzheimer’s cortex, reported scientists at the Human Amyloid Imaging conference in Miami. Other speakers correlated UCB-J uptake with amyloid and tau PET and cognitive decline, strengthening the case for its use as an AD biomarker. The tracer also picks up dramatic synapse loss in frontotemporal dementia and progressive supranuclear palsy, and modest declines in early Parkinson’s disease.